Leaflet FEMKE 30mg film-coated tablets
Indicated for: contraception
Route of administration: oral
Substance: ulipristal acetate (hormonal contraceptive)
ATC: G03AD02 (Genito urinary system and sex hormones | Hormonal contraceptives for systemic use | Emergency contraceptives)
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Ulipristal acetate is a medication primarily used for the treatment of uterine fibroids and as an emergency contraceptive. It is a selective progesterone receptor modulator (SPRM) that works by inhibiting the activity of progesterone, a hormone essential for fibroid growth and ovulation.
In the treatment of uterine fibroids, ulipristal is administered orally, usually in courses lasting several months, to reduce the size of fibroids and associated symptoms such as heavy bleeding and pelvic pain. As an emergency contraceptive, it is used to prevent pregnancy after unprotected sexual intercourse if taken within 120 hours.
Common side effects include headache, nausea, abdominal discomfort, and changes in the menstrual cycle. In rare cases, allergic reactions or liver function impairment may occur.
Ulipristal acetate is an effective and versatile medication used both in the management of uterine fibroids and as a method of emergency contraception.
General data about FEMKE 30mg
- Substance: ulipristal acetate
- Date of latest medicines list: 01-01-2022
- Product code: W68320001
- Concentration: 30mg
- Pharmaceutical form: film-coated tablets
- Quantity: 1
- Product type: Generic medicine
- Prescription status: OTC - Over the Counter = medicine that does not require a medical prescription.
Pharmaceutical forms available for ulipristal acetate
Concentrations available for ulipristal acetate
- 30mg
- 5mg